The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the phase I trial of cetuximab with mitomycin c and 5-fluorouracil concurrent with radiotherapy treatment in patients with muscle-invasive bladder cancer.
 
Syed A. Hussain
Honoraria - Bayer Schering Pharma; Pierre Fabre
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; Pierre Fabre
Research Funding - Boehringer Ingelheim (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Boehringer Ingelheim; Janssen
 
Carey Hendron
No Relationships to Disclose
 
Laura Buckley
No Relationships to Disclose
 
Lynne Dickinson
No Relationships to Disclose
 
Isabel Syndikus
No Relationships to Disclose
 
Zafar Malik
No Relationships to Disclose
 
Chinnamani Eswar
No Relationships to Disclose
 
Nicholas David James
Honoraria - Astellas Pharma; Bayer; Janssen; Oncogenex; Pierre Fabre; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Merck; Sanofi
Speakers' Bureau - Astellas Pharma; Ferring; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Pfizer (Inst); Sanofi (Inst)